Viewing Study NCT00781105


Ignite Creation Date: 2025-12-25 @ 3:36 AM
Ignite Modification Date: 2026-01-28 @ 8:06 PM
Study NCT ID: NCT00781105
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2008-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module